Actively Recruiting
Dental Implant Healing With TNF-Alpha Inhibitors
Led by University of Pennsylvania · Updated on 2026-05-11
30
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
N
Nobel Biocare
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this pilot study is to learn about healing after dental implant placement in patients taking a class of biologic drug called Tumor Necrosis Factor or TNF-alpha antagonist or inhibitor. The main questions it aims to answer are: Do patients taking TNF-alpha inhibitors have any complications after the placement of dental implants? Do patients taking TNF-alpha inhibitor experience increased pain after dental implant placement compared to the expected levels when healing from this procedure? Researchers will recruit patients both taking these drugs and those not taking these drugs to compare the outcomes between the two groups. Participants missing teeth will be recruited to receive dental implants to meet ideal dental status and will be followed before and after the implant placement to determine levels of health and ensure proper healing. Participants will be followed for a total of one year and follow up visits will consist of both clinical examination and radiographs (x-rays) to evaluate bone level and implant status. Participants will also be asked to rate their pain during clinic visits and at home on a diary and record the amount of pain control medication they take after the implant procedure.
CONDITIONS
Official Title
Dental Implant Healing With TNF-Alpha Inhibitors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over the age of 18
- Require placement of implants to assist with dental restoration
- Taking a stable dose of TNF-alpha inhibitor medication for at least 6 months, or not taking TNF-alpha inhibitors but matched by age and gender
- Medically fit to withstand implant placement as judged by the study team
- Able to read and speak English
- Able to provide independent consent or attend visits with a surrogate decision maker
You will not qualify if you...
- Presence of periodontal disease with pockets above 4mm or significant bone loss
- Evidence of cyst or tumor formation in the jawbone on radiographs
- Uncontrolled diabetes with HbA1c greater than 8.0
- History of head and neck radiation
- Use of antiresorptive or antiangiogenic agents
- Not medically fit for implant placement or unable to seek outpatient care
- Tobacco or tobacco product use within the last year
- Pregnancy (typically excluded as implant placement is elective and deferred until after delivery)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania School of Dental Medicine
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
S
Stacey Secreto
CONTACT
K
Katherine Theken, PharmD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here